In colorectal cancer (CRC), its high expression is associated with poor prognosis, and pharmacological inhibition of ANO1 suppresses tumour growth by downregulating Wnt/β-catenin signalling [44,45]. This evidence concerns the gene ANO1 and neoplasm.